Gufic Biosciences gets DCGI nod for Thymosin Alpha-1 in Covid-19

Gufic Biosciences has secured approval from the Drugs Controller General of India (DCGI) for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment ... Read More